GlaxoSmithKline agrees to USD20 million penalty with SEC for FCPA violations | Practical Law
The SEC has announced its agreement to accept an offer to settle charges against GlaxoSmithKline that its China-based subsidiaries violated the internal controls and record keeping provisions of the FCPA.